BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Bio NC

  Mayne Pharma Launches Clozapine Tablets in the United States

  Clozapine tablets are a generic alternative to Clozaril, indicated as an antipsychotic.

  November 8, 2017

   · 

  5 min read
• Business

  TRACON Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update

  Cash, cash equivalents and short-term investments were $35.9 million at September 30, 2017, compared to $44.4 million at December 31, 2016.

  November 8, 2017

   · 

  10 min read
• Business

  BioArctic Interim Report January - September 2017

  Net sales for the period amounted to SEK 31.5M.

  November 8, 2017

   · 

  9 min read
• Business

  Vigene Biosciences Partners With The Michael J. Fox Foundation to Distribute Alpha-synuclein Knockdown Viral Vectors for Parkinson’s Disease Research

  Viral vectors to knockdown mouse or human alpha-synuclein (aSyn) will be made available for purchase in early 2018.

  November 8, 2017

   · 

  1 min read
• Business

  Bellicum Reports Third Quarter 2017 Financial Results

  Bellicum reported a net loss of $23.4 million for the third quarter of 2017 and $69.9 million for the nine months ended September 30, 2017.

  November 8, 2017

   · 

  9 min read
• Business

  Kura Oncology Reports Third Quarter 2017 Financial Results and Provides Corporate Update

  Management to host webcast and conference call today at 4:30 p.m. ET.

  November 8, 2017

   · 

  8 min read
• Business

  Aeglea BioTherapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results

  On September 30, 2017, Aeglea had available cash, cash equivalents and marketable securities of $55.7 million.

  November 8, 2017

   · 

  7 min read
• 

  Job Trends

  Exact Sciences to Create 250 New Jobs With Facility Expansion

  World-class lab and office space to support demand for Cologuard.

  November 8, 2017

   · 

  9 min read
• Business

  VBL Therapeutics to Report Third Quarter 2017 Results on November 14

  The company will host a conference call and live audio webcast at 8:30am ET to report third quarter ended September 30, 2017 financial results.

  November 8, 2017

   · 

  1 min read
• Business

  Sientra Reports Third Quarter 2017 Financial Results

  Total net sales for the third quarter 2017 were $9.8 million, compared to total net sales of $6.5 million for the same period in 2016.

  November 8, 2017

   · 

  14 min read